VANCOUVER, British Columbia and HOLMDEL, N.J., Sept. 23, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB) for phoneless, tokenless, passwordless and phish-resistant authentication experiences, announced that its long-time customer, the province of British Columbia, has placed new orders with BIO-key. 10,000 users will be added to their existing deploy ...

MINNEAPOLIS, Sept. 18, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today issued its 2024 Corporate Sustainability Report (CSR), detailing the continued progress advancing its Environmental, Social and Governance (ESG) initiatives. Bio-Techne's CSR is organized around four key pillars: Our People, Advancing Science, Governance and Operational Integrity, and The Environment. Bio-Techne's EPIC values (Empowerment, Passion, Innovation and Collaboration) remain the backbone of our corporate cultur ...

HOLMDEL, N.J., Sept. 12, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB) for phoneless, tokenless, passwordless and phish-resistant authentication experiences, today announced it has entered into a warrant inducement agreement with an existing institutional investor for the immediate exercise of certain outstanding warrants that the Company issued on ...

HOLMDEL, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB) for phoneless, tokenless, passwordless and phish-resistant authentication experiences, announced that one of the world’s most respected government defense ministries has awarded BIO-key over $500K in new orders for BIO-key’s biometric user authentication solution pursuant to a t ...

HOLMDEL, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) software featuring passwordless, phoneless and token-less Identity-Bound Biometrics (IBB) authentication solutions, will participate at H.C. Wainwright’s 26th Annual Hybrid Global Investment Conference September 9th and 10th. BIO-key’s CEO Mike DePasquale will be available for virtual meetings on Monday and Tuesday, September 9th ...

文章核心观点 - 公司的Digital PCR业务增长强劲,Droplet Digital PCR平台表现出色 [5][6] - 公司的临床诊断业务持续增长,主要得益于质控和血型产品需求的增加 [7][8] - 公司财务状况稳健,现金和现金等价物充足,偿债能力强 [9] - 但生物制药业务疲软,受到宏观经济环境的不利影响 [10][11][12] - 公司面临成本压力,毛利率受到原材料价格上涨、物流成本增加和员工成本上升的影响 [13] - 公司面临激烈的竞争压力,价格竞争加剧 [14][15] 公司概况 - 公司是一家临床诊断和生命科学研究产品的制造商和全球供应商 [3] - 公司市值为89.2亿美元 [3] - 过去5年公司的收益增长率为15.6%,远高于行业3.7%的增长率 [4] - 公司的季度业绩表现良好,超出预期的概率较高 [4] 业务表现 - Digital PCR业务增长强劲,公司正在不断提高产能以满足需求 [5][6] - 临床诊断业务中的糖尿病、免疫血液学和质控业务表现良好 [7][8] - 生物制药业务受到宏观经济环境的不利影响,出现需求下降 [10][11][12] 财务状况 - 公司现金和现金等价物充足,偿债能力强 [9] - 但面临成本压力,毛利率受到不利影响 [13] 竞争环境 - 公司面临激烈的竞争压力,价格竞争加剧 [14][15]

HOLMDEL, N.J. , Aug. 15, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) software featuring passwordless, phoneless and token-less Identity-Bound Biometrics (IBB) authentication solutions, announced the availability of its PortalGuard IDaaS platform in the Amazon Web Services (AWS) Marketplace enabling AWS customers around the world to seamlessly purchase and integrate PortalGuard and its IBB authenti ...

HOLMDEL, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced results for its second quarter ended June 30, 2024 (Q2’24). Note, BIO-key’s results for 2023 were restated at year-end and filed with the Company’s 2023 Form 10-K, and as a result Q2’23 and six months ended June 30, ...

Bio-Rad's (BIO) business performance has been affected by Biopharma’s softness, macroeconomic conditions in China and competitive pressure. The stock carries a Zacks Rank #4 (Sell).Since the beginning of 2023, Bio-Rad has been witnessing softness in smaller BioPharma companies, where historically, demand for life science products has been strong. This directly correlates with the funding constraints the broader pharmaceutical industry has been experiencing. Management puts forth that BioPharma’s softness ha ...

文章核心观点 - 公司将于2024年8月15日举行Q2 2024财报电话会议 [1][2] - 公司是一家提供身份和访问管理以及身份绑定生物识别解决方案的创新型公司 [3] - 公司的PortalGuard IAM解决方案提供成本效益高、易部署、方便和安全的访问计算机、信息、应用程序和高价值交易的功能 [3] 会议信息 - 会议时间为2024年8月15日上午10点ET [2] - 会议拨号号码为美国1-877-418-5460或国际1-412-717-9594 [2] - 会议网络直播和重播链接可用3个月 [2] - 会议重播号码为美国1-877-344-7529或国际1-412-317-0088,密码为7767803 [2] 公司信息 - 公司名称为BIO-key International, Inc. [1][3] - 公司股票代码为NASDAQ: BKYI [1] - 公司网址为www.BIO-key.com [3] - 公司为超过4000万用户提供生物识别为中心的多因素身份和访问管理软件 [3] - 公司允许客户为不同使用场景选择合适的身份验证因素,包括无手机、无令牌和无密码的生物识别选项 [3] 投资者联系方式 - 投资者联系人为William Jones和David Collins,来自Catalyst IR [5] - 投资者联系邮箱为BKYI@catalyst-ir.com [5] - 投资者联系电话为212-924-9800 [5]